News BHI EIR Renée JG Arnold Shares Expertise at the 28th Annual International ISPOR Meeting Renée JG Arnold, PharmD, RPh, who serves as an Entrepreneur-in-Residence at BHI NHLBI EIR, recently moderated and participated in a…AndyMay 15, 2023
News Women In Bio announces appointment of Gina Ford as Executive Director Women In Bio is proud to announce that Gina Ford has joined our team as Executive Director. Gina brings a wealth of…AndyMay 15, 2023
News Join AURP in Boston for a Deep Dive into Building Communities of “Biotech Innovation”! Join AURP in Boston for a Deep Dive into Building Communities of Biotech Innovation! Before the 2023 BIO International Conference…AndyMay 15, 2023
News Navigating the Challenges of Rare Disease Research with Dr. Harsha Rajasimha on BioTalk Join us for an enlightening episode of BioTalk with Rich Bendis as we explore the pivotal role of patient registries…AndyMay 15, 2023
News Raising Awareness: Indo US Bridging RARE Summit 2023 to Shine a Spotlight on Rare Diseases Scheduled for October 29-30, 2023, at the George Mason University Campus in Arlington, VA, the Indo US Bridging RARE Summit…AndyMay 11, 2023
News Rockville’s MaximBio Inks Contract with National Institutes of Health (RADx) Centered on a new Rapid Platform ROCKVILLE, Md. , May 9, 2023 /PRNewswire/ -- MaximBio® is proud to announce it has signed a new agreement with the National Institutes of Health…AndyMay 9, 2023
News TEDCO Announces Investment into Rise Therapeutics Biotech company receives follow-on funding to accelerate ongoing clinical development efforts COLUMBIA, Md. (May 8, 2023) – TEDCO, Maryland’s economic engine for…AndyMay 8, 2023
News MaxCyte Signs Strategic Platform License with Walking Fish Therapeutics to Support the Development of its Innovative B Cell Platform Walking Fish to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to engineer novel B-cell based medicines for the treatment…AndyMay 5, 2023
News US FDA approves GSK’s Arexvy, the world’s first respiratory syncytial virus (RSV) vaccine for older adults Ground-breaking approval enables adults aged 60 years and older to be protected from RSV disease for the first time The…AndyMay 5, 2023
News Gain Therapeutics Awarded CHF 2.5 million Innosuisse Grant to Advance Lead Program in GBA1 Parkinson’s Disease BETHESDA, Md., May 03, 2023 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX), a biotechnology company leading the discovery and…AndyMay 3, 2023